Previous symbols: FAS1, APT1, TNFRSF6. Aliases: CD95, APO-1.
FAS (CD95/APO-1) is a death receptor that triggers extrinsic apoptosis. CRITICAL ISOFORM BIOLOGY: Alternative splicing produces 7 isoforms with ANTAGONISTIC functions: (1) Membrane-bound isoform 1 (P25445-1) forms the DISC with FADD and CASP8 to trigger apoptosis; (2) Soluble isoforms 2-6 (lacking transmembrane domain) act as DECOY RECEPTORS that BLOCK apoptosis by binding FasL without signaling. UniProt states "The secreted isoforms 2 to 6 block apoptosis (in vitro)". The GOA has BOTH GO:0043065 (positive regulation) AND GO:0043066 (negative regulation) of apoptosis - this reflects isoform conflation where membrane and soluble forms have opposite effects. LIGAND-FORM CHECKPOINT: membrane-bound FasL (mFASL) drives canonical apoptotic DISC signaling, while soluble FasL (sFASL) preferentially biases toward NON-APOPTOTIC programs (NF-kB, MAPK, PI3K/AKT) via alternative membrane-associated complexes (FADDosome/MISC), supporting inflammation, migration, and proliferation (Hu 2025 PMID:40330016; Seyrek et al. 2024 PMID:39513921). HUMAN GENETICS: heterozygous FAS variants cause autoimmune lymphoproliferative syndrome (ALPS); a 2024 cohort of 802 referred patients found pathogenic/likely-pathogenic FAS variants in 6.5% of the total cohort, with 58% located in the intracellular domain and 57% of those being missense changes in the death domain - underscoring the death domain as the critical functional module for in vivo apoptotic signaling (Xu et al. 2024 PMID:39060684).
Relationship is the entry's genetic[].relationship_type. untyped means the entry has a genetic record for the gene but does not type it; its free-text association is shown instead.
| Disorder | Relationship | Where the gene appears |
|---|---|---|
| Autoimmune Lymphoproliferative Syndrome | causative |
mechanism: Defective Fas-Mediated Lymphocyte Apoptosis
subtype: ALPS-FAS; ALPS-sFAS
scoped to subtype: ALPS-FAS
|
| Evans Syndrome | causative germline |
mechanism: Loss of Lymphocyte Self-Tolerance
|
| Rosai-Dorfman Disease | susceptibility germline | |
| FAS-related Autoimmune Lymphoproliferative Syndrome |
untyped
CAUSATIVE
|
mechanism: Defective Fas-mediated apoptosis of activated lymphocytes
|
| Multisystem Inflammatory Syndrome in Children (MIS-C) |
untyped
Implicated in immune dysregulation
|
mechanism: T-Cell Receptor Vβ21.3 Skewing and IL-18-FAS Activation
|
| Stevens-Johnson Syndrome | no genetic record |
mechanism: Fas-FasL Keratinocyte Apoptosis
|
| Systemic Lupus Erythematosus | no genetic record |
animal model: MRL/lpr
|
An entry matches when ClinGen's MONDO disease is the entry's own disease term, a subtype term, or an exact-match mapping. An amber status marks an entry ClinGen supports the gene for (Definitive, Strong or Moderate) whose own record does not type it. A Limited, Disputed or Refuted tier on such an entry is not a gap.
| ClinGen disease | MOI | Classification | dismech entry |
|---|---|---|---|
| FAS-related autoimmune lymphoproliferative immune disorder MONDO:1060194 | SD | Definitive 2025-10-14 |
Autoimmune Lymphoproliferative Syndrome
causative
|
Identity from HGNC (snapshot 2026-10-01). Page layers are described in the gene pages documentation.